Last reviewed · How we verify
NCT04360395
Igniting Mobility in Adolescents and Young Adults With Cerebral Palsy
NA trial testing Gait Therapy in Cerebral Palsy in 120 participants. Participants enrolled and being followed up; not accepting new ones.
31 May 2025
Quick facts
| Lead sponsor | Father Flanagan's Boys' Home |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 3 August 2020 |
| Primary completion | 31 May 2025 |
| Estimated completion | 31 May 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Gait Therapy
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
Sponsor
Father Flanagan's Boys' Home
Who can join
Adults 13 to 18, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study design will consist of a cohort of adolescents and young adults with cerebral palsy (CP) that will undergo a gait training protocol. All participants will complete MEG or EEG baseline brain imaging measures of their sensorimotor cortical activity, MRI brain/spinal cord imaging (previous MRI or template brain may be substituted), neurophysiological tests of the spinal cord H-reflex, and a series of mobility clinical tests and cognitive tests. Participants with metal in their body that would interfere with the MEG (e.g., braces on teeth, permanent retainer) will not undergo the MEG tests but will undergo the EEG assessments. Those who complete the MEG assessments will not undergo the EEG assessments. After completing the baseline tests, the participants with CP will undergo the therapeutic gait training. After completing all of the therapeutic gait training sessions, the participants with CP will repeat the same assessments that were completed at baseline. Separately, a cohort of neurotypical adolescents and young adults will also complete the baseline assessments. The neurotypical participants will not undergo the therapeutic gait training, but will be used as a normative group for interpreting if the changes seen in the participants with CP after therapy are in fact moving the system toward a normative state.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Overground gait training improves the sensorimotor cortical dynamics and mobility of persons with cerebral palsy.
Busboom MT, Spooner RK, Chinen LS, Baker SE, et al · · 2025 · PMID 41192147 · DOI 10.1016/j.nicl.2025.103901
Verify or expand the search:
- PubMed search for NCT04360395
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other Father Flanagan's Boys' Home trials
Trials by the same sponsor.
- NCT06794476 — Milieu Teaching-AV (MT-AV Pilot) · NA · withdrawn
- NCT06852664 — Improving Activity in Individuals With Cerebral Palsy · NA · recruiting
- NCT05815537 — Development of Functional Spatial Hearing in Reverberation · EARLY_PHASE1 · completed
- NCT04558541 — A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production · NA · recruiting
- NCT05486637 — Vocal Emotion Communication With Cochlear Implants · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04360395 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Father Flanagan's Boys' Home
- Last refreshed: 29 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04360395.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing